Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
GlobeNewswire
OXFORD, United Kingdom, April 29, 2024 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading..
OXFORD, United Kingdom, April 29, 2024 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading..
*April 5, 2024*
*Announcement no. 7*
*New Board Candidate for the upcoming Annual Geneal..
Dublin, March 05, 2024 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report..